Literature DB >> 36245678

Posttransplant considerations in autoimmune liver disease: Recurrence of disease and de novo.

Alexis Gumm1, Antonio Perez-Atayde2, Andrew Wehrman1.   

Abstract

Entities:  

Year:  2022        PMID： 36245678      PMCID： PMC9549300          DOI： 10.1002/cld.1239

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  40 in total

1.  Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.

Authors:  Keith D Lindor; Christopher L Bowlus; James Boyer; Cynthia Levy; Marlyn Mayo
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

2.  Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.

Authors:  Jennifer E Guy; Peiqing Qian; Jeffrey A Lowell; Marion G Peters
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

3.  Histologic surveillance after liver transplantation due to autoimmune hepatitis.

Authors:  Lauri Puustinen; Sonja Boyd; Perttu Arkkila; Helena Isoniemi; Johanna Arola; Martti Färkkilä
Journal:  Clin Transplant       Date:  2017-04-12       Impact factor: 2.863

4.  Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.

Authors:  Aya Miyagawa-Hayashino; Hironori Haga; Hiroto Egawa; Yasuaki Hayashino; Takaki Sakurai; Sachiko Minamiguchi; Koichi Tanaka; Toshiaki Manabe
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

5.  Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions.

Authors:  Kristel K Leung; Maya Deeb; Sandra E Fischer; Aliya Gulamhusein
Journal:  Semin Liver Dis       Date:  2021-06-28       Impact factor: 6.115

Review 6.  Liver transplantation and autoimmune liver diseases.

Authors:  Rodrigo Liberal; Yoh Zen; Giorgina Mieli-Vergani; Diego Vergani
Journal:  Liver Transpl       Date:  2013-08-13       Impact factor: 5.799

7.  Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.

Authors:  R S Venick; S V McDiarmid; D G Farmer; J Gornbein; M G Martin; J H Vargas; M E Ament; R W Busuttil
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

8.  Sirolimus in pediatric liver transplantation: a single-center experience.

Authors:  N E M Gibelli; U Tannuri; M L Pinho-Apezzato; A C A Tannuri; J G Maksoud-Filho; W C Andrade; M C P Velhote; M M Santos; A A R Ayoub; M Marques da Silva
Journal:  Transplant Proc       Date:  2009-04       Impact factor: 1.066

9.  Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.

Authors:  Mercedes Martinez; Emily R Perito; Pamela Valentino; Cara L Mack; Madeleine Aumar; Annemarie Broderick; Laura G Draijer; Eleonora D T Fagundes; Katryn N Furuya; Nitika Gupta; Simon Horslen; Maureen M Jonas; Binita M Kamath; Nanda Kerkar; Kyung Mo Kim; Kaija-Leena Kolho; Bart G P Koot; Trevor J Laborda; Christine K Lee; Kathleen M Loomes; Tamir Miloh; Douglas Mogul; Saeed Mohammed; Nadia Ovchinsky; Girish Rao; Amanda Ricciuto; Alexandre Rodrigues Ferreira; Kathleen B Schwarz; Vratislav Smolka; Atsushi Tanaka; Mary E M Tessier; Venna L Venkat; Bernadette E Vitola; Marek Woynarowski; Melissa Zerofsky; Mark R Deneau
Journal:  Hepatology       Date:  2021-09-09       Impact factor: 17.298

10.  Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.

Authors:  Gwilym James Webb; Abbas Rana; James Hodson; Mohammed Zeeshan Akhtar; James Walter Ferguson; James Max Neuberger; John Moore Vierling; Gideon Morris Hirschfield
Journal:  Clin Gastroenterol Hepatol       Date:  2017-10-06       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.